Neutral endopeptidase 24.11 (NEP, CD10) is a cell-surface enzyme expressed by prostatic epithelial cells that cleaves and inactivates neuropeptides implicated in the growth of androgen-independent prostate cancer (PC). NEP substrates such as bombesin and endothelin-1 induce cell migration. We investigated the mechanisms of NEP regulation of cell migration in PC cells, including regulation of phosphorylation on tyrosine of focal adhesion kinase (FAK). Western analyses and cell migration assays revealed an inverse correlation between NEP expression and the levels of FAK phosphorylation and cell migration in PC cell lines. Constitutively expressed NEP, recombinant NEP, and induced NEP expression using a tetracycline-repressive expression system inhibited bombesin-and endothelin-1-stimulated FAK phosphorylation and cell migration. This results from NEPinduced inhibition of neuropeptide-stimulated association of FAK with cSrc protein. Expression of a mutated catalytically inactive NEP protein also resulted in partial inhibition of FAK phosphorylation and cell migration. Coimmunoprecipitation experiments show that NEP associates with tyrosine-phosphorylated Lyn kinase, which then binds the p85 subunit of phosphatidylinositol 3-kinase (PI3-K) resulting in an NEP-Lyn-PI3-K protein complex. This complex competitively blocks FAK-PI3-K interaction, suggesting that NEP protein inhibits cell migration via a protein-protein interaction independent of its catalytic function. These experiments demonstrate that NEP can inhibit FAK phosphorylation on tyrosine and PC cell migration through multiple pathways and suggest that cell migration which contributes to invasion and metastases […] Article Find the latest version:
Introduction
The molecular events involved in prostate cancer (PC) development and progression are not well defined.
Neutral endopeptidase 24.11 (NEP, CD10) is a cell-surface enzyme expressed by prostatic epithelial cells that cleaves and inactivates neuropeptides implicated in the growth of androgen-independent prostate cancer (PC). NEP substrates such as bombesin and endothelin-1 induce cell migration. We investigated the mechanisms of NEP regulation of cell migration in PC cells, including regulation of phosphorylation on tyrosine of focal adhesion kinase (FAK). Western analyses and cell migration assays revealed an inverse correlation between NEP expression and the levels of FAK phosphorylation and cell migration in PC cell lines. Constitutively expressed NEP, recombinant NEP, and induced NEP expression using a tetracycline-repressive expression system inhibited bombesin-and endothelin-1-stimulated FAK phosphorylation and cell migration. This results from NEP-induced inhibition of neuropeptide-stimulated association of FAK with cSrc protein.
Expression of a mutated catalytically inactive NEP protein also resulted in partial inhibition of FAK phosphorylation and cell migration. Coimmunoprecipitation experiments show that NEP associates with tyrosine-phosphorylated Lyn kinase, which then binds the p85 subunit of phosphatidylinositol 3-kinase (PI3-K) resulting in an NEP-Lyn-PI3-K protein complex. This complex competitively blocks FAK-PI3-K interaction, suggesting that NEP protein inhibits cell migration via a protein-protein interaction independent of its catalytic function. These experiments demonstrate that NEP can inhibit FAK phosphorylation on tyrosine and PC cell migration through multiple pathways and suggest that cell migration which contributes to invasion and metastases in PC cells can be regulated by NEP.
other biological properties in addition to its ability to catalytically inactivate neuropeptide substrates and that NEP protein expression in of itself can effect signal transduction pathways which regulate cell growth (9, 10) and apoptosis (11) . In the present study, we used LNCaP cells and hormone-independent TSU-Pr1 PC cells to investigate the mechanisms of NEP action by assessing the effects of NEP on regulating phosphorylation of focal adhesion kinase (FAK) on tyrosine and cell migration.
Methods
Cell culture and reagents. PC cell lines were maintained in RPMI 1640 media supplemented with 2 mM glutamine, 1% nonessential amino acids, 100 U/ml streptomycin and penicillin, and 10% FCS. Reagents used include recombinant NEP (rNEP; Arris Pharmaceuticals Corp., South San Francisco, California, USA); CGS24592 (Novartis Pharmaceuticals, Summit, New Jersey, USA) (12) ; and PP2 (Calbiochem-Novabiochem Ltd., La Jolla, California, USA). The following antibodies were used: mouse monoclonals to NEP (J5; Beckman Coulter, Fullerton, California, USA); to Lyn (H-6), to cSrc (B-12), to anti-pTyr (PY20; Santa Cruz Biotechnology Inc., Santa Cruz, California, USA); rabbit polyclonals to NEP (5B5; Arris Pharmaceuticals Corp.), to p85 (Upstate Biotechnology, Lake Placid, New York, USA), to FAK (C-20), to Lyn (clone 44), and to cSrc (SRC-2; Santa Cruz Biotechnology Inc.).
Plasmid construction and gene transfer. TSU-GK27-NEP (WT-5) and TSU-GK27-Neo (TN-12) cells were constructed and maintained as described previously (6) . A mutated NEP gene containing a substitution of Val for the catalytic Glu residue was constructed by PCR-based site-directed mutagenesis (13) . A 1,525-bp PCR DNA fragment was cloned and sequenced entirely to confirm the presence of the mutation and the absence of other bp changes. A 1,339-bp DNA fragment containing the mutated region was used to replace the equivalent fragment in the expression vector pSVCALLA, which, when transfected into COS-1 cells, promoted the expression of high amounts of human NEP but no enzymatic activity, as reported previously for the same mutation in rabbit NEP (14) . A DNA fragment containing the mutated sequence was used to replace the equivalent fragment in the pTRE-NEP vector. The pTRE-mutated NEP vector was then introduced into TSU-GK27 cells and stable cell lines expressing an inducible mutated NEP protein isolated (M-22 cells) as described elsewhere (6) .
Enzyme assays. Cells were incubated with or without tetracycline, and NEP-specific enzyme activity assays were performed on total cell lysates as described previously (15) using Suc-Ala-Ala-Phe-pNA (Bachem Bioscience Inc., Philadelphia, Pennsylvania, USA) as substrate. Specific activities were expressed as picomoles per milligram of protein per minute and represent an average of two separate measurements performed in duplicate.
Immunoprecipitation and immunoblotting. Cells were lysed in 1 ml of RIPA buffer (10 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% Triton X-100, 5 mM EDTA, 1% sodium deoxycholate, 0.1% SDS, 1.2% aprotinin, 5 µM leupeptin, 4 µM antipain, 1 mM phenylmethylsulfonyl fluoride, and 0.1 mM Na 3 VO 4 ); 300-500 µg was incubated 1 hour to overnight with 1-4 µg primary antibody and for 1 hour with 40 µl protein G-Sepharose beads (Amersham Pharmacia Biotech, Piscataway, New Jersey, USA) at 4°C; and immunoprecipitates were washed with RIPA buffer, resuspended in 2x Laemmli sample buffer, resolved on 8% or 10% SDS-PAGE, and transferred to nitrocellulose. Western blot analyses were performed as described previously (15) using 1:2,000 dilution of antibody. For Far Western analysis, membranes were incubated with 1 µg/ml GST fusion protein containing the COOH-terminal Src-homology (SH) 2 domain of p85 subunit of PI3-K (Upstate Biotechnology) for 2 hours and then Western blotted using the anti-GST mAb (1:2,000; Santa Cruz Biotechnology Inc.) and anti-mouse secondary antibody. Relative intensities of each band were measured by NIH image and levels of phosphorylated protein relative to total protein calculated as the phosphorylation ratio. All experiments were performed on at least two separate occasions using different cell lysates with similar results.
Cell migration assays. Migration experiments were performed using 10 mm Tissue Culture Inserts with 8.0 µm polycarbonate membranes (Nalge Nunc, Naperville, Illinois, USA) as described elsewhere (2) with minor modifications. Membranes were coated with 100 µl of 1 mg/ml of MATRIGEL matrix (Becton Dickinson Labware, Bedford, Massachusetts, USA) for 1 hour at room temperature, followed by 2% BSA in PBS as a blocking reagent for 1 hour. After overnight culture in serum-free media (LNCaP, TSU-Pr1, DU145, and PC-3) or culture for 48 hours in media containing tetracycline and/or CGS24592 (WT-5, TN-12, and M-22), cells were harvested, washed, and resuspended in serum-free RPMI1640 and added to the upper chambers at concentrations of 5 × 10 4 cells per well. Media in upper and lower chambers contained serum-free RPMI1640 with bombesin or ET-1 at appropriate concentrations or 10% FCS (LNCaP, TSU-Pr1, DU145, and PC-3); or serum-free RPMI1640 with or without tetracycline (WT-5, TN-12, and M-22). CGS24592, rNEP, and PP2 were added to cells in upper chambers and to the media in lower chambers 2 hours before other reagents. Cells were allowed to migrate for 10 hours at 37°C in a humidified atmosphere containing 5% CO 2 . Membranes were fixed and stained using a Diff-Quik Stain Set (Dade Behring Inc., Deerfield, Illinois, USA). Nonmigrated cells on the upper side of the membrane were removed with a cotton swab. Migrated cells attached to the lower side of the membrane were enumerated using a light microscope at 10× magnification. Each data point represents the average cell number of six independent microscopic fields from a single experiment. Statistical analyses were performed using an unpaired t test. All migration assays were performed on three separate occasions with similar results.
Results

NEP enzymatic activity inhibits FAK phosphorylation and cell migration in PC cells. Focal adhesion kinase (FAK)
is an important component of integrin-mediated signal transduction and plays a key role in modulating cell migration of PC cells (2, 16) . FAK is activated through tyrosine phosphorylation, which occurs after cell adhesion to ECM proteins and ligand binding of growth factors to their cell-surface receptors, and FAK phosphorylation on tyrosine-397 is necessary for FAK-promoted cell migration (17) . Anti-pTyr Western blotting of FAK immunoprecipitates revealed low levels of FAK phosphorylation and a slightly lower amount of total FAK protein in androgen-sensitive LNCaP cells compared with the levels of FAK phosphorylation and FAK protein in androgen-independent, TSU-Pr1, DU145, and PC-3 PC cells ( Figure 1a , panels 2 and 3), which inversely correlated with the amount of NEP protein in these cells ( Figure 1a , panel 1). TSU-Pr1, DU145, and PC-3 cells ability to migrate through Matrigel was 9.7-, 9.1-, and 12.2-fold higher, respectively, then LNCaP cells (P < 0.005 for all three cell lines).
NEP neuropeptide substrates bombesin and ET-1 stimulate phosphorylation of FAK (18, 19) and promote the migration of highly metastatic PC cells through ECM but have minimal effects on LNCaP cells (20) . Inhibition of NEP enzymatic activity in LNCaP cells cultured in RPMI containing FCS using the NEP competitive enzyme inhibitor CGS24592 for 2 hours at concentrations ranging from 0 to 100 nM resulted in increased FAK phosphorylation on tyrosine in a dose-dependent fashion ( Figure 1b Figure 2c , cell migration studies performed using the identical conditions depicted in Figure 2b demonstrated that expression of NEP in WT-5 cells resulted in a greater than 90% decrease compared with control (P < 0.005), which was partially reversed by 100 nM CGS24592. NEP expression in M-22 cells resulted in a 54% decrease (P < 0.005), which was less than that observed in WT-5 cells but comparable to the inhibition observed in WT-5 cells cultured with CGS24592. These data show that blocking NEP enzyme activity through either a competitive enzyme inhibitor or gene mutation does not completely abrogate the ability of cell-surface NEP to inhibit FAK phosphorylation and cell migration and suggest that expression of the NEP protein at the cell surface can induce dephosphorylation of FAK through a mechanism distinct from NEP's catalytic function.
NEP enzyme activity inhibits the formation of cSrc and FAK protein complexes. The ability of FAK to transmit signals to downstream targets is dependent on its interaction with several intracellular signaling molecules including Src family kinases (21, 22) and PI3-K (23). Tyr-397 has been identified as the major site of FAK autophosphorylation and the binding site for the SH2 domains of cSrc (24) and the p85 subunit of PI3-K (23). Substitution of Tyr-397 with Phe abolishes FAK-promoted cell migration (17) , implicating a role for cSrc and PI3-K in cell migration. The association of FAK with cSrc is also critical in promoting bombesin-mediated FAK phosphorylation and cell migration via G protein-coupled receptor (GPCR) pathways (19, 25) . Western blotting of cSrc immunoprecipitates from PC cells revealed that FAK coimmunoprecipitates with cSrc in three androgen-independent PC cell lines but not in LNCaP cells (Figure  3a) , despite the fact that LNCaP cells express abundant amounts of cSrc protein (Figure 3a, lower panel) and FAK protein (Figure 1a, panel 3) . The FAK-cSrc coimmunoprecipitation was partially restored by culturing LNCaP cells in media containing FCS with CGS24592 (data not shown), or in serum-free media with CGS24592 followed by ET-1 (Figure 3b, lane 4) . In TSU-Pr1 cells, the specific Src kinase inhibitor PP2 inhibited bombesin-induced FAK phosphorylation (Figure 3c , lane 3 compared with lane 2). A total of 10 µM PP2 also inhibited FAK phosphorylation in TSU-Pr1 cells cultured in media containing FCS (Figure 3c , lane 5 compared with lane 4). This decrease in FAK phosphorylation was not affected by the addition of 50 µg/ml of rNEP for 2 hours before the addition of PP2 (Figure 3c, lane 6) . Cell migration assays showed that treatment of TSU-Pr1 cells with 10 µM PP2 resulted in 45% decrease in migrated cell number compared with untreated control (P = 0.0025), and that the addition of 50 µg/ml rNEP did not significant affect the migrated cell number compared with PP2 treatment (P = 0.3907). Finally, assessment of the association of cSrc and FAK in WT-5, M-22, and TN12 cells before and after tetracycline withdrawal showed that FAK and cSrc coimmunoprecipitated in WT-5 ( Figure  3d p85 coimmunoprecipitates could be detected when either wild-type or mutated NEP was expressed after tetracycline withdrawal (Figure 5b, panels 1 and 4) . Thus, these data suggest that NEP protein complexes with the p85 subunit of PI3-K and inhibits the association of p85 with FAK, and that expression of catalytically inactive NEP protein in M22 cells partially inhibits FAK phosphorylation and cell migration by NEP complexing with p85.
Lyn kinase mediates p85-NEP interaction. NEP's cytoplasmic domain lacks any characteristic structural motifs such as an SH2 domain or a proline-rich region required for associating with p85, suggesting that NEP and p85 do not directly associate. NEP is reported to associate with the Src family kinase member Lyn and an unknown 75-to 85-kDa protein in B cells (9, 10) . Our study showed that Lyn was also detected by Western blotting of NEP immunoprecipitates with a Lyn antibody in NEP-expressing LNCaP, WT-5 and M-22 cells (data not shown). Similarly, Western blotting of Lyn immunoprecipitates with an NEP antibody detected NEP ( Figure 6,  a and b, panel 1) . Moreover, p85 coimmunoprecipitated with NEP and Lyn ( Figure 6, a and b, panel 2) , and antipTyr Western blotting of Lyn immunoprecipitates showed that Lyn phosphorylation is increased in cells expressing NEP (Figure 6 , a and b, panel 3 compared with total Lyn protein in panel 4). Lyn directly associates with p85 when NEP is expressed as shown by binding of GST-p85 SH2 to Lyn immunoprecipitated from M-22 cells expressing NEP after tetracycline withdrawal (Figure 6c) . Finally, an analysis of immunoprecipitates of p85 from M-22 cells at 8, 16, and 24 hours after tetracycline withdrawal indicated that the p85-FAK association (Figure 6d, panel 1) decreased as the association of p85 with both NEP (Figure 6d, panel 2) and Lyn (Figure 6d,  panel 3) increased. Taken together, these results suggest that NEP associates with and induces Lyn phosphorylation, which in turn directly binds to p85 of PI3-K, resulting in complex of NEP-Lyn-PI3-K, which competitively blocks FAK-PI3-K interaction, leading to a decrease in FAK phosphorylation and cell migration.
Discussion
The involvement of NEP loss in the transition from androgen-dependent PC to androgen-independent PC has only recently been recognized (6) . We previously reported that NEP expression is decreased in many androgen-independent PCs in vivo (6) ; that the NEP gene is transcriptionally activated by androgen and that androgen withdrawal results in decreased NEP expression (6, 15) ; and that hypermethylation of the 5′ CpG NEP island in the NEP promoter is asso- ciated with loss of NEP expression (27) . These results suggest a model in which decreased NEP expression is facilitated by the elimination of androgens or hypermethylation of the NEP promoter, contributing to the development of neuropeptide-mediated, androgen-independent PC cell growth. The current study aimed at elucidating the mechanisms of NEP action on PC cells reveals a dual function of the NEP protein ( Figure 7 ). NEP inhibits neuropeptide-mediated stimulation of the association of cSrc and FAK through catalytic inhibition of its neuropeptide substrates such as bombesin and ET-1, and NEP inhibits the association of PI3-K with FAK by indirectly associating with PI3-K through Lyn kinase. These effects on FAK phosphorylation directly correlate with PC cell migration, and suggest that NEP normally functions to regulate PC cell migration and possibly other FAKassociated processes.
The effects of NEP on bombesin and ET-1 are not surprising as these neuropeptides induce FAK activation via a cSrc-dependent pathway (19, 28) . The association of FAK with cSrc plays a major role in FAK-mediated signal transduction (29) , inducing phosphorylation of FAK at multiple sites, including Tyr 577 and Tyr 925, resulting in maximal FAK activity (29, 30) . We show that cell migration, FAK phosphorylation and the association of cSrc with FAK (a) increases in NEP-negative, androgen-independent PC cells treated with neuropeptide; (b) increases in NEP-expressing LNCaP cells cultured with a specific NEP enzyme inhibitor plus neuropeptide; and (c) decreases with the addition of rNEP or the expression of cell-surface NEP in androgen-independent PC cells. These results suggest that NEP enzymatic activity inhibits FAK phosphorylation and cell migration by affecting neuropeptide-induced interaction of FAK with cSrc. Expression of a mutated, catalytically inactive cellsurface NEP protein also inhibited FAK phosphorylation and cell migration although to a lesser degree than observed following expression of wild-type NEP. This observation suggested another mechanism of NEP action distinct from its enzymatic function, and led us to examine whether PI3-K, which has been implicated in promoting cell migration, was involved. The concept that NEP protein independent of its catalytic activity is involved in signal transduction is supported by two recent studies. NEP/CD10 expression is a marker for apoptosis in T cells and the apoptotic capacity is not dependent of NEP catalytic activity (11) , and NEP/CD10 expression negatively affects integrin-mediated signal transduction in NEP/CD10 positive B lymphocyte leukemia cells (31) . Our observation that NEP protein associates with the p85 subunit of PI3-K was unexpected. This association occurs in LNCaP cells and in androgen-independent PC cells in which NEP expression is induced. Expression of NEP in these cells is also associated with a loss of the interaction of p85 with FAK. Numerous studies have suggested that FAK associates with PI3-K (23, 26, 32) and this association affects the integrity of the actin cytoskeleton (32) and cell migration (26) , although it remains controversial whether PI3-K-mediated cell migration is dependent on FAK (26, 33) . Thus, we hypothesize that in PC cells NEP's effect on cell migration and FAK phosphorylation is also mediated by inhibition of FAK-PI3-K interaction.
Although we have shown that tyrosine-phosphorylated Lyn that is induced following NEP expression inhibits FAK-PI3-K interactions by associating directly with p85, we did not define the enzyme that phosphorylates Lyn, or how an NEP-phosphorylated Lyn complex inhibits PI3-K associating with FAK. NEP is present in detergent-resistant glycosylphosphatidylinositol (GPI) microdomains (10) , which are enriched in various signaling molecules, including p85 and its substrate PIP2 (34) . NEP in GPI microdomains coimmunoprecipitates with Lyn and an unknown 75-to 85-kDa protein (9, 10), which we speculate is p85. It is unclear whether the intracellular domain of NEP is necessary for these interactions; however, GPI-anchored cell-surface proteins lacking an intracellular domain coprecipitate with other Src-related protein tyrosine kinases (35) , suggesting that the intracellular domain of NEP may not be required. PI3-K located in focal contacts can reactivate integrin function through inside-out signaling (36, 37) , suggesting that PI3-K associates with FAK in focal contacts and also regulates FAK-mediated cell migration pathways. In addition, Lyn has previously been implicated as a negative regulator of PI3-K signaling (38, 39) . Thus, we speculate that NEP expression results in phosphorylated Lyn binding PI3-K causing PI3-K to translocate from focal contacts (which contain integrin-FAK complexes), thereby inhibiting FAK-PI3-K interactions. Preliminary studies support this hypothesis (our unpublished data).
In summary, we describe a novel dual function of NEP to inhibit FAK phosphorylation and cell migration by blocking FAK association with cSrc and PI3-K, suggesting a complex system in which NEP plays an important role. Recent studies showing that bombesin signaling cross-talks with the EGF receptor (40) , and that ET-1 acts as a survival factor (41) , suggest that NEP may be involved in other critical pathways. Further studies will help define the role of NEP and its substrates in regulating PC development and progression. 
